Editorial: There will be another pandemic. We should be more, not less, prepared.
The Trump administration has cut funding for vaccine research since COVID-19 is not a pandemic but coronaviruses and ...
The U.S. Needs More Antiviral Drugs
Its overdependence on vaccines leaves the country vulnerable to bioterrorism.
H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics
Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on ...
The Bird Flu Virus Is Mutating Fast – And Scientists Say Our Vaccines May Not Be Enough
H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...
Fierce Pharma6d
Bharat Biotech enters cell and gene therapy market with $75M production investment: reports
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
Healio13d
Study: Live vaccines safe, effective in pediatric transplant recipients
Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective ...
Healio9d
NIH launches trial of Lassa fever vaccine
The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.